Formulary Watch Drug Shortage Tracker — September 19, 2021

September 19th 2021

FDA Advisory Committee Supports COVID-19 Boosters for Some People

September 18th 2021

The vaccines advisory committee voted late on Friday, September 17, 2021, to provide emergency authorization of Pfizer’s COVID-19 vaccine as a booster for those over the age of 65, as well as for those at high risk of developing severe disease.

AbbVie Submits Rinvoq to FDA and EMA for Ulcerative Colitis

September 17th 2021

Rinvoq achieved primary and secondary end points compared with placebo.

Pfizer Recalls All Lots of Smoking Cessation Drug Chantix

September 17th 2021

To date, Pfizer has not received reports of adverse events related to this recall, but is making the move as a precaution.

FDA Expands EUA for Lilly’s COVID-19 Monoclonal Antibody

September 16th 2021

The combination of bamlanivimab/etesevimab can now be given to both treat and prevent COVID-19 infection after exposure.